Clinical Trials at USC

3 Results for

Study Title	Principal Investigator
Evaluating Nulojix Long-Term Safety in Transplant Time Perspective: Prospective for the majority of patients who are enrolled at the time they begin Nulojix (belatacept) treatment. Retrospective for any patients receiving Nulojix (belatacept) prior to enrollment into ENLiST Registry Completed \| Kidney Transplant \| Multisite View full trial information >>	Bristol-Myers Squibb
A Three-Part, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Sequential Adaptive, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of OPN-305, a Humanised Monoclonal Antibody That Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function Completed \| Kidney Transplant \| Multisite View full trial information >>	Robert Miller
Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based Immunosuppression Completed \| Kidney Transplant \| Multisite View full trial information >>	Bristol-Myers Squibb